March 29, 2024 17:56 (IST)
NovaLeadPharma announces successful completion of global phase I , II clinical trial for Galnobax
Mumbai/Kolkata, Nov 3 (IBNS): NovaLead Pharma, a drug discovery and development company, on Tuesday announced a potential breakthrough in the treatment of diabetic foot ulcers (DFU), which is a frequent complication of uncontrolled diabetes over a period of time.
Latest Headlines